Emerald Advisers’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.1M | Sell |
1,021,257
-124,234
| -11% | -$5.36M | 1.62% | 11 |
|
|
2025
Q1 | $39.6M | Sell |
1,145,491
-5,377
| -0.5% | -$186K | 1.78% | 9 |
|
|
2024
Q4 | $31.6M | Buy |
1,150,868
+47,360
| +4% | +$1.3M | 1.22% | 25 |
|
|
2024
Q3 | $28.1M | Buy |
1,103,508
+437,164
| +66% | +$11.1M | 1.09% | 31 |
|
|
2024
Q2 | $16.9M | Sell |
666,344
-32,739
| -5% | -$829K | 0.71% | 55 |
|
|
2024
Q1 | $21.6M | Buy |
699,083
+13,544
| +2% | +$419K | 0.87% | 43 |
|
|
2023
Q4 | $27.7M | Sell |
685,539
-8,461
| -1% | -$342K | 1.18% | 21 |
|
|
2023
Q3 | $18.3M | Buy |
694,000
+214,875
| +45% | +$5.67M | 0.89% | 43 |
|
|
2023
Q2 | $8.24M | Buy |
+479,125
| New | +$8.24M | 0.36% | 97 |
|